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Abstract
Normally the immune response is restricted to the peripheral secondary lymphoid organs.
However, additional ectopic lymphoid tissue may develop at chronic sites of inflammation. In
the synovium of rheumatoid arthritis patients the local production of proinflammatory
cytokines seems to support the formation of a precisely structured microenvironment, which
allows an antigen dependent immune response to take place. The analysis of the V-gene
repertoire expressed in synovial B cells demonstrated that in the inflamed synovium a
germinal centre reaction takes place. Antigen presented by a network of follicular dendritic
cells may activate synovial B cells and support their differentiation into plasma cells
secreting high affinity antibodies. The specificity of these antibodies remains to be
determined.
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Introduction
Despite intensive efforts we still have no clear idea regard-
ing what induces inflammation in synovial membrane. This
inflammation may result in hyperplasia of synoviocytes,
infiltration of mononuclear cells, neoangiogenesis, pannus
formation and finally joint destruction. One major problem
in investigating the induction and progression of this
chronic inflammation is that there is great heterogeneity
from patient to patient in the appearance of the chronically
inflamed synovial tissue (ST) [1]. One relatively constant
feature, however, is the appearance of infiltrating lympho-
cytes in the majority of inflamed ST specimens [2,3].
These infiltrates are often diffuse and lack a distinct struc-
tural organization. Small clusters of T and B cells may be
seen in the vicinity of the vasculature and plasma cells
may accumulate in the inflamed tissue. In about 10% of
the patients, though, the infiltrating lymphocytes become
organized into large follicle-like structures, suggesting the
development of so-called tertiary lymphoid tissue. The
main cellular component in these structures is activated
B cells, which can differentiate locally into plasma cells.
Molecular analysis demonstrates that these B cells take
part in an antigen-driven specific immune response in this
ectopic lymphoid tissue [4–6]. The unresolved question is
whether this is an autoimmune reaction directly related to
the pathogenesis of rheumatoid arthritis (RA) or whether it
is merely a bystander effect induced by the chronic inflam-
mation. This review briefly describes our current knowl-
edge of the immune processes that take place in the
synovial membrane of patients with RA.
Phenotypic characterization of the synovial
tissue
The normal synovium is a relatively acellular structure, con-
taining a thin lining layer of synoviocytes. The sublining is
made up of an extracellular matrix in which blood vesselshttp://arthritis-research.com/content/2/2/126
and a scattering of fat cells, fibroblasts and occasionally
mononuclear cells are embedded. The picture is quite dif-
ferent for inflamed synovium of patients with RA [7], in
which there is an extensive infiltration of macrophages,
T and B cells into the sublining region. In many such
patients, large perivascular cellular aggregates form,
which have a well-organized follicle-like structure (Fig. 1).
In these large infiltrates the main cellular components are
B cells (Fig. 1a), and three different subsets can readily be
distinguished. These subsets are as follows: terminally dif-
ferentiated plasma cells that surround the follicular struc-
tures (Fig. 1f); mature CD20+ B cells that are in close
interaction with CD4+ helper T cells; and activated B cells
that have a germinal centre (GC) phenotype (Fig. 1b–e),
which proliferate in a network of follicular dendritic cells
(FDCs) in the middle of the follicle-like structure (summa-
rized in Table 1).
The generation of ectopic germinal centres
In organ-specific autoimmune diseases the development
of ectopic GCs is frequently observed within the affected
tissue [8–10]. It is likely that proinflammatory cytokines,
such as tumour necrosis factor-a, that are found in the
areas of chronic inflammation play a major role in the for-
mation of additional lymphoid tissue [11]. Immigrating
B cells may further promote the organization of GCs in the
inflamed tissue. B cells express the proinflammatory
cytokine lymphotoxin-a as a membrane bound lympho-
Figure 1
Organization of B lymphocytes in synovial follicular structures. Labelling of serial sections with antibodies specific for (a) CD20, (b) follicular
dendritic cells, (c) Ki67, (d) CD79, (e) CD38 and (f) plasma cells. Original magnification 100×.
(b) (a) (c)
(e) (d) (f)toxin-a/lymphotoxin-b heterotrimer or as a soluble lympho-
toxin-a homotrimer. Analyses of immune-deficient mice
[12,13] have demonstrated that only in the presence of
lymphotoxin-a-expressing B cells does a network of FDCs
develop. Thus, B cells themselves produce cytokines that
are essential for the formation of GCs.
The germinal centre reaction
A normal GC is a highly organized structure within which
the affinity maturation of the humoral immune response
takes place [14–16]. In a T-cell-dependent immune
response these structures develop from the primary B-cell
follicles of the peripheral lymphoid organs, such as the
spleen and the lymph nodes. In a fully developed GC a
dark and a light zone can be distinguished [17,18]. In the
dark zone antigen-activated B cells proliferate and the
somatic hypermutation mechanism is switched on, allow-
ing single nucleotide exchanges to be introduced into the
rearranged V-region genes [15,16]. By this means a single
activated B cell that is recruited into the GC gives rise to
multiple variants, each of which may have a different affin-
ity for the antigen. The light zone consists of a network of
FDCs. These are highly specialized cells that present
antigen–antibody complexes bound via the Fc or the com-
plement receptor on their surface. It is thought that com-
petition for the antigen determines which of the B-cell
variants are selected for further differentiation and survival
and which will die through apoptosis [14]. Only those
B cells with a high-affinity receptor will receive the signals
necessary for differentiation into plasma or memory cells.
Classical GCs with a distinguishable dark and light zone
are seen only rarely in inflamed ST [19,20]. The proliferat-
ing B cells that express a GC phenotype are embedded
within the network of FDCs [5] even in large synovial cell
clusters, which may contain several thousand cells. A
similar picture has been described for splenic GCs in
mice that are deficient for the chemokine receptor CXCR5
[21,22]. In such mice no primary follicles develop, but
when a T-cell-dependent immune response is induced
ectopic GCs develop in the T-cell zone of the spleen [22].
The antigen-activated B cells proliferate and differentiate
in a network of FDCs. Thus, in these CXCR5-deficient
mice the process of affinity maturation occurs indepen-
dently of the development of a dark and a light zone.
B-cell activation in the network of follicular
dendritic cells
To determine whether the synovial lymphoid structures
can support a GC reaction, the subset of synovial follicular
B cells (Table 1) that express a GC phenotype was iso-
lated directly from frozen tissue sections, DNA was pre-
pared, and the rearranged V-region genes were amplified,
cloned and sequenced [5]. The overall finding was that a
heterogeneous population of B cells that express a broad
spectrum of V-gene rearrangements accumulates within
the network of FDCs. For example, when 50 individual
B cells were dissected from the network of FDCs in a
single follicular structure, 13 different VH, five Vl and two
Vk functional rearrangements were recovered. By compar-
ison with the known human germline genes it is clear that
the majority of these sequences (16 out of 20) were
unmutated. These B cells therefore appeared to be recent
immigrants from the peripheral blood, and had been acti-
vated by antigen presented on the FDCs.
The finding of sequences with an identical V(D)J
rearrangement, but with a different pattern of somatic
mutations suggested that a few activated B cells can be
channelled by the FDC network into a GC reaction. In
each of the follicular structures examined [5] there was
only an oligoclonal population of B cells in which the
hypermutation mechanism was activated. Figure 2 shows
the intraclonal diversification of synovial B cell clones iso-
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Table 1
Immunohistological characterization of synovial follicular
infiltrates
B cells in the network B cells associated
Marker of FDC (GC phenotype) with T cells Plasma cells
CD20 + + –
CD79 Low + –
Ki67 + – –
CD38 Low – +
WUE-1 – – +
VS38c – – +
FDC, follicular dendritic cell; GC, germinal centre.
Figure 2
Intraclonal diversification in synovial germinal centre. Genealogical
trees showing the diversification of a DPL23 (Vl3 germline gene) and
an O18 (Vk1 germline gene) rearrangement. Numbered circles
represent isolated sequences. The DPL23 rearrangement was isolated
from two independent polymerase chain reactions (prefixes 1 and 2),
and the O18 rearrangement was from serial sections 1, 2, 4 and 5.
Numbers beside the lines refer to the number of nucleotide exchanges
by which one sequence differs from the other sequences.lated from the network of FDCs. The mutational pattern
suggests that both naïve and memory cells are selected
into a GC reaction. In the VlDPL23 rearrangement all
sequences had only a single somatic mutation in common,
indicating that a naïve B cell was activated in the synovial
follicular structure. During proliferation in the network of
FDCs, up to nine additional nucleotide exchanges accu-
mulated. In contrast, the genealogical tree of a Vk O18
rearrangement suggested that the clone developed from a
memory cell, because all sequences had five somatic
mutations in common.
Clonal expansion in the synovial tissue
The rate of hypermutation has been estimated to be
around 10–3/base pair per generation [23]. If the activated
B cells have a division time of approximately 8 h [14] then
one would expect roughly one substitution each day in a
V-gene of 300 nucleotides. Thus, the finding of sequences
that have accumulated up to nine nucleotide exchanges
during clonal expansion in the ST demonstrates the enor-
mous proliferative capacity of the activated B cell. A single
synovial B cell can generate clones numbering several
thousand cells within a week. The majority of these cells
are presumably not selected and will die through apopto-
sis. A few will differentiate into plasma cells or perhaps
into memory cells, however.
V-gene repertoire expressed in synovial B cells
An analysis of the functional in-frame V-genes expressed
in the ST was performed. The summary of 134 different
VH, 31 different Vl and 21 different Vk rearrangements
[4,5] clearly showed that a broad spectrum of V-genes is
expressed in synovial B cells. For example, the majority
(80%) of the known human VH3 genes were found to be
expressed in synovial B cells (Fig. 3). The frequency with
which these various VH3 sequences were found was non-
random. Thus, out of a total of 66 VH3 sequences exam-
ined, 19 were from the VH gene 3-23 and 15 from the
closely related sequences 3-30, 3-30.3, 3-30.5 and 3-33.
In addition, the VH4 genes 4-39 and 4-59 and the VH5
gene 5-51 were found more frequently than one would
expect (data not shown). Similar nonrandom VH gene
usage is seen in the peripheral blood B cells of healthy
individuals [24]. The only unexpected feature of the B cell
rearrangements was an enhanced frequency of VH 4-39
usage. Although the number of tissue samples was small,
this excess of VH 4-39 rearrangements was seen in three
out of five patients analyzed.
Plasma cell differentiation in the synovial
tissue
To examine the antigen-specific immune response within
the inflamed synovium, we compared the V-gene reper-
toire used by B cells taken from the network of FDCs, from
the T cell area and from the ring of plasma cells of individ-
ual lymphoid structures [5]. This analysis showed that the
repertoire expressed by the plasma cells was significantly
different from that expressed in the CD20+ B cells isolated
from the network of FDCs. In the plasma cells, there was a
significant shift towards rearrangements of the VH4 gene
http://arthritis-research.com/content/2/2/126
Figure 3
VH3 repertoire of synovial B cells. The number of the different rearrangments isolated from the synovial tissue samples of five patients with RA is
given. VH3 sequences were compared with the known human germline genes [29].family. This suggests that only a small fraction of the broad
spectrum of B cells migrating into the FDC network are
selected to differentiate into plasma cells. The low fre-
quency of VH 3-23 rearrangements seen in the population
of plasma cells (two out of 37 sequences) is in accord
with this interpretation.
The next question concerns the origin of these plasma
cells. Although the analysis failed to identify plasma cells
and CD20+ B cells with an identical rearrangement, the
data are nevertheless in favour of plasma cell differentia-
tion within the ST. Within the plasma cell population we
found sequences with an identical rearrangement but a
different pattern of somatic mutations [5], indicating that
these plasma cells have developed from the same B-cell
clone. One might argue that the intraclonal diversification
occurred during B-cell activation in a GC of the normal
peripheral lymphoid tissue. However, the probability that
the descendants of a B cell activated in normal lymphoid
tissue migrate independently into the ST and settle in
close vicinity of the same follicle is extremely low.
We favour an explanation that is based on the kinetics of
B-cell development that results in a temporal dislocation of
clonal relationships. In this scenario peripheral B cells con-
tinuously immigrate into the synovial lymphoid structures.
Only those few that express appropriate V genes will be
selected into a GC reaction and only those clonal descen-
dants with high affinity for the selecting antigen will differ-
entiate into plasma cells. The plasma cells that are present
within a follicular structure are thus descendants of B cells
that were activated days or perhaps weeks before in the
network of FDCs. The B cells currently in the FDC
network are the forerunners of the plasma cells that will
develop over the course of the coming days and weeks.
Specificity of synovial B cells
The central question that remains is which antigens drive
the specific immune response and select B cells to differ-
entiate. One possibility is that the synovial membrane
functions as additional lymphoid tissue. In this case, the
elaboration of a normal immune response is no longer
restricted to the peripheral lymphoid organs, but can also
take place in the ectopic lymphoid tissue that has devel-
oped in the ST. Another possibility is that we are dealing
with an autoimmune response that is initiated in the syn-
ovial membrane. Though it remains unclear whether the
synovial immune response is the causal basis of the
disease, patients with RA do often have autoantibodies
[25]. The so-called rheumatoid factor (RF) are autoanti-
bodies specific for the Fc region of self-immunoglobulin G.
Indeed, around 60% of RA patients have high affinity
immunoglobulin M, and immunoglobulin G and immuno-
globulin A RF antibodies. These RF antibodies are useful
prognostic markers, because seropositive patients have a
more erosive and a more destructive disease. The extent
to which B cells activated in the follicular structures of the
ST have RF specificity remains to be determined. Interest-
ingly, when hybridoma lines with RF specificity were gen-
erated from the ST of a patient with RA [26], two lines
were found that expressed an identical VH gene
rearrangement. The highly mutated line showed an
increased affinity for self-immunoglobulin. These findings
suggest that RF-specific B cells undergo affinity matura-
tion in the ST.
The impact of B cells on the pathogenesis of
rheumatoid arthritis
Antibodies with RF specificity will lead to the formation of
immunoglobulin complexes and by activation of the com-
plement cascade enhance the chronic inflammatory
process. Furthermore, B cells with specificity for self-
immunoglobulin can bind and internalize immunoglobu-
lin–antigen complexes and hence by generating a much
broader spectrum of peptides lead to enhanced antigen-
presenting function [27]. This will support further activa-
tion and maturation of self-reactive B cells and thereby
increase the production of high-affinity antibodies with RF
specificity. If indeed the majority of the synovial B cells
have RF specificity, this may lead to a continuous stimula-
tion of the immune system and thus support the chronic
inflammatory processes.
There is as yet little evidence that antibodies are directly
involved in tissue destruction. This question remains open,
however. Intriguing recent evidence comes from a mouse
model system in which it has been demonstrated that anti-
bodies with specificity for a commonly expressed enzyme
of the glycolytic pathway, the glucose-6-phosphate iso-
merase, induce RA-like symptoms [28]. Whether autoanti-
bodies of a comparable specificity are involved in the
pathogenesis of human RA has to be established.
Conclusion
The molecular analysis of the V-gene repertoire expressed
in synovial B cells has demonstrated that within the
inflamed synovium an antigen dependent immune
response takes place. By combining the immunohistologi-
cal information with the molecular data it will be possible
to determine the specificity of those B cells involved in an
antigen driven immune response. The aim is to micro-
dissect single cells from the ST, analyze their V-region
genes and clone them into expression vectors. This will
reveal the impact of the ongoing immune response on the
pathogenesis of the disease.
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